Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neisseria gonorrhoeae-specific genomic sequences refer to unique DNA regions, such as strain-specific islands like the gonococcal genetic island (GGI), repetitive elements (e.g., DNA uptake sequences), and variable loci used in typing schemes, distinguishing this pathogen from related Neisseria species. These sequences enable high rates of horizontal gene transfer, facilitating rapid evolution and the acquisition of antimicrobial resistance determinants, notably mosaic penA alleles that confer resistance to extended-spectrum cephalosporins like ceftriaxone. In gonorrhea, the primary disease caused by N. gonorrhoeae, these genomic features drive multidrug-resistant clones, such as NG-MAST ST1407, which have spread globally and challenge standard treatments. Typing methods like NG-MAST, NG-STAR, MLST, and cgMLST leverage these sequences to track lineages, recombination events, and resistance patterns, with tools like LIN codes providing stable classification amid high genetic diversity. Targeting these sequences indirectly supports diagnostics and surveillance, though direct therapeutic modulation remains unexplored due to their non-protein nature; instead, they inform antibiotic stewardship amid rising resistance threats.
Sequence variations confer penicillin-binding protein modifications (e.g., penA mosaics reduce cephalosporin binding affinity) Horizontal gene transfer spreads resistance determinants across strains
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neisseria gonorrhoeae-specific genomic sequences.